Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

KYTH 49.31
price chart
Why Keith Leonard Unloaded 3500 Shares of Kythera Biopharmaceuticals Inc ...
In view of the deal Keith Leonard made he is in the bear's eye today. The President & CEO of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) 49.31 -0.10 -0.20% and an insider, made a sale of 3,500 shares worth $175,151 USD. The average price was ...
Notable Session Mover: Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH)  Vanguard Tribune
Kythera Biopharmaceuticals Inc (KYTH) Insider Keith R Leonard Sells 3500 ...  News Watch International
Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) Announces FDA Approval of ...
Kythera Biopharmaceuticals Inc. (NASDAQ:KYTH) opened trading today as $45.24 and is trading in the range of 45.12-51.84 today.
Elisabeth Sandoval, an Insider in Kythera Biopharmaceuticals Inc (NASDAQ ...  OctaFinance.com
All Analysts Say Buy Kythera Biopharmaceuticals (NASDAQ:KYTH)  Stock Markets Daily
Sell Kythera (KYTH) Stock, Another Biotech Ripoff
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) stock was halted Monday as an independent advisory committee reviewed its double-chin treatment, ATX-101.
KYTHERA Biopharmaceuticals Announces Pricing of Public Offering of Common ...  GlobeNewswire (press release)
FDA Panel Backs Kythera Double-Chin Treatment  Wall Street Journal
Why Kythera Biopharmaceuticals, Inc Rocketed Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
FDA Panel Backs Drug that Reduces Double Chin  Newsmax
Kythera Biopharmaceuticals Inc. (KYTH) Jumps 5.23% on May 20
Kythera Biopharmaceuticals Inc. (KYTH) was among the biggest gainers on the Russell 2000 for Wednesday May 20 as the stock popped 5.23% to $51.12, representing a gain of $2.54 per share.
Analysts Expect Kythera Biopharmaceuticals to Announce ($1.10) Earnings Per ...  The Legacy
Reasons for Keith Leonard's Shares Sale of Kythera Biopharmaceuticals Inc ...
13,548 shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) 49.31 -0.10 -0.20% were unloaded by Keith Leonard, the corporation's President & CEO.
Kythera Biopharmaceuticals CEO Keith R. Leonard Sells 13548 Shares (KYTH)  WKRB News
Is Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) Stock a Sell after Keith ...
At an average stock price per share of $50.5, Keith Leonard, the Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) 49.31 -0.10 -0.20% 's President & CEO unloaded 2,709 shares of Kythera Biopharmaceuticals Inc worth roughly $136,869 US Dollars. This is ...
Insider Selling: Kythera Biopharmaceuticals CEO Sells $136858.68 in Stock ...  The Legacy
Photo Release -- KYTHERA Biopharmaceuticals Announces FDA Approval of ...
WESTLAKE VILLAGE, Calif., April 29, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) announced today that the U.S.
FDA approves treatment for fat below the chin  FDA.gov
Why KYTHERA Biopharmaceuticals Inc. Shares Shot Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
KYTHERA Acquires Rights to ATX-101 Outside of the US and Canada From ...  MarketWatch
Kythera Regains ATX-101 from Bayer  Zacks.com
Related articles »  
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
WESTLAKE VILLAGE, Calif., May 19, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on May 15, 2015, the Compensation Committee of the Company's Board of Directors granted four new employees ...
Brokerage Views on Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH)  Markets Daily